Opioid prescribing has declined in recent years, but nonetheless remains high for the chronic kidney disease population.
All articles by Natasha Persaud
The comparative efficacy of these therapies has been extended to patients with stage 3 chronic kidney disease, a common comorbidity in gout.
The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care.
COVID-19 severity at hospital admission predicts complications even in young adults and those without pre-existing health conditions.
A study found no significant increased risks for death or major adverse cardiac events among infected patients with established chronic kidney disease or end-stage kidney disease.
Findings support COVID-19 vaccination of patients on dialysis but suggest that a shift in vaccine strategy for kidney transplant recipients may be warranted.
The most common inappropriate medications included proton pump inhibitors, alpha blockers, and NSAIDs.
Study findings highlight the importance of following the clinical trial vaccine administration protocol in patients receiving hemodialysis, according to investigators.
Older adults and individuals with diabetes did not experience a faster decline in SARS-CoV-2 antibody titers, investigators found.
Routine pain assessments using validated scales are vital to develop personalized management strategies, according to investigators.